한글목차

세계 바이오프로세스 최적화 및 디지털 바이오매뉴팩처링 시장 규모는 2024년 243억 달러에서 예측 기간 동안 CAGR 10.2%로 추이하고 2029년 말 396억 달러에 이를 것으로 예측됩니다.

북미 시장은 2024년 90억 달러에서 예측 기간 동안 CAGR 10.0%로 추이하고, 2029년 말에는 145억 달러에 달할 것으로 예측되고 있습니다. 유럽 시장은 2024년 72억 달러에서 CAGR 9.7%로 성장을 지속하여 2029년 말에는 115억 달러에 달할 것으로 예측됩니다.

이 보고서는 세계 바이오프로세스 최적화 및 디지털 바이오 매뉴팩처링 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규 환경, 신기술 및 기술 개발 동향, 시장 규모 추이· 예측, 각종 구분· 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 분석

제2장 시장 개요

• 개요
• 기술 배경
• 생물 제제 제조 공정
• 업스트림 처리
• 세포의 채취와 정제
• 다운스트림 처리
• 바이오프로세스 최적화
• 인더스트리 4.0: 디지털 바이오 제조

제3장 시장 역학

• 세계 시장 역학
• 시장 성장 촉진요인
• 고령화 인구 증가
• 만성 질환 증가
• 바이오의약품 수요가 과거 없을 만큼 증가
• 제품 발매수 증가
• 계약 제조 조직(CMO) 증가
• 시장 성장 억제요인
• 숙련 노동자의 부족
• 설비 비용이 높다
• 조화되지 않은 스마트 제조 표준
• 시장 기회
• 유리한 정부 프로그램
• 센서 기술의 진보
• 프로세스 분석 기술의 대처
• 시장의 과제
• 기술적인 문제와 사이버 공격의 위협
• 규제 상황
• 적정 자동화 제조 규범(GAMP)
• ISA(Instrumentation, Systems, and Automation) Society : 88?95 표준

제4장 신기술과 개발

• 새로운 동향과 기술
• 연속 바이오프로세스
• 연속 세포 유지 기술
• 연속 크로마토그래피
• 일회용 기술

제5장 시장 세분화 분석

• 주요 시장 동향
• 세분화의 내역
• 시장 분석 : 기술별
• 제조 기술
• 분석 및 공정 제어 기술
• 소프트웨어
• 시장 분석 : 용도별
• 바이오 제조 공정의 자동화 및 제어
• 유연한 제조
• 바이오프로세스 최적화 및 프로세스 분석
• 기타
• 시장 분석 : 분자 유형별
• 단클론항체(mAbs)
• 치료용 단백질과 펩티드
• 백신
• 세포 및 유전자 치료
• 지리적 내역
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 주요 기업의 랭킹
• 기업이 채용한 주요 전략
• 협업과 파트너십
• 확대
• 인수
• 신제품 발매

제7장 바이오프로세스 최적화 및 디지털 바이오 제조 시장에서의 지속가능성 : ESG의 관점

• ESG: 소개
• 업계의 ESG 실천
• 환경 성능
• 사회적 퍼포먼스
• 거버넌스 퍼포먼스
• 기업의 ESG 리스크 평가
• BCC에 의한 총론

제8장 부록

• 조사 방법
• 정보원
• 참고문헌
• 약어
• 기업 프로파일
• AGILENT TECHNOLOGIES INC.
• AGILITECH
• BIO-RAD LABORATORIES INC.
• BRUKER
• CLEAN BIOLOGICS
• DANAHER CORP.
• EMERSON ELECTRIC CO.
• EPPENDORF SE
• KORBER AG
• MERCK KGAA
• SARTORIUS AG
• SHIMADZU CORP.
• THERMO FISHER SCIENTIFIC INC.
• UNIVERCELLS TECHNOLOGIES
• WATERS CORP.

영문목차

The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.

The North American bioprocess optimization and digital biomanufacturing market is expected to grow from $9.0 billion in 2024 and is projected to reach $14.5 billion by the end of 2029, at a CAGR of 10.0% during the forecast period of 2024 to 2029.

The European bioprocess optimization and digital biomanufacturing market is expected to grow from $7.2 billion in 2024 and is projected to reach $11.5 billion by the end of 2029, at a CAGR of 9.7% during the forecast period of 2024 to 2029.

Report Scope

The report provides a comprehensive analysis of the bioprocess optimization and digital biomanufacturing market in a global context, including market forecasts and sales through the year 2029. Segmentation based on technology type includes manufacturing technologies (chromatography-based separation and purification, filtration, bioreactors, centrifugation), analytical and process control technologies (spectrophotometry, automation and industrial process control technologies, analytical chromatography, sensors and probes), and software (Industrial control and automation software, bioprocess optimization and data analytics software). Segmentation based on application includes biomanufacturing process automation and control, flexible manufacturing, bioprocess optimization and process analytics, and others. By molecule type the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins and peptides, and cell and gene therapies. The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

The report discusses the critical issues impacting the adoption of digital biomanufacturing in pharmaceuticals, as well as emerging trends in digital biomanufacturing technologies. It also features new developments and new product launches in the global market. The report provides comprehensive profiles of market players in the industry. The report also covers mergers and acquisitions and any other collaborations or partnerships that occurred during the evaluation period of this report and which are expected to shape the industry.

Report Includes

• 69 data tables and 61 additional tables
• Analyses of trends in the global market for bioprocess optimization and digital bio-manufacturing, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
• Estimates of the market size and revenue growth prospects of the global market, along with a market share analysis by technology, application, drug molecule type and region
• Facts and figures pertaining to the market dynamics, technical advances, regulations and the impact of macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Analysis of patents, emerging trends, and new developments
• Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and ESG scores and practices of leading companies
• Profiles of the market leaders, including Agilent Technologies Inc., Thermo Fisher Scientific Inc., Danaher Corp., and Sartorius AG.

Table of Contents

Chapter 1 Introduction

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Technology Background
• Biologics Manufacturing Process
• Upstream Processing
• Cell Harvesting and Clarification
• Downstream Processing
• Bioprocess Optimization
• Industry 4.0-Digital Biomanufacturing

Chapter 3 Market Dynamics

• Global Market Dynamics
• Market Drivers
• Growing Aging Population
• Increasing Prevalence of Chronic Diseases
• Unprecedented Rise in Demand for Biopharmaceuticals
• Growing Number of Product Launches
• Increasing Number of Contract Manufacturing Organizations (CMOs)
• Market Restraints
• Lack of Skilled Labor
• High Cost of Equipment
• Unharmonized Smart Manufacturing Standards
• Market Opportunities
• Favorable Government Programs
• Advances in Sensor Technology
• Process Analytical Technology Initiatives
• Market Challenges
• Technical Issues and the Threat of Cyberattacks
• Regulatory Landscape
• Good Automation Manufacturing Practices (GAMP)
• Instrumentation, Systems, and Automation (ISA) Society-88 and 95 Standards

Chapter 4 Emerging Technologies and Developments

• Emerging Trends and Technologies
• Continuous Bioprocessing
• Continuous Cell Retention Technologies
• Continuous Chromatography
• Single-Use Technologies

Chapter 5 Market Segmentation Analysis

• Key Market Trends
• Segmentation Breakdown
• Market Analysis by Technology
• Manufacturing Technologies
• Analytical and Process Control Technologies
• Software
• Market Analysis by Application
• Biomanufacturing Process Automation and Control
• Flexible Manufacturing
• Bioprocess Optimization and Process Analytics
• Other Applications
• Market Analysis by Molecule Type
• Monoclonal Antibodies (mAbs)
• Therapeutic Proteins and Peptides
• Vaccines
• Cell and Gene Therapies
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Ranking of Leading Players
• Key Strategies Adopted by Players
• Collaborations and Partnerships
• Expansion
• Acquisitions
• New Product Launches

Chapter 7 Sustainability in the Bioprocess Optimization and Digital Biomanufacturing Market: An ESG Perspective

• Introduction to ESG
• ESG Practices in the Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Companies' ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Methodology
• Information Sources
• References
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• AGILITECH
• BIO-RAD LABORATORIES INC.
• BRUKER
• CLEAN BIOLOGICS
• DANAHER CORP.
• EMERSON ELECTRIC CO.
• EPPENDORF SE
• KORBER AG
• MERCK KGAA
• SARTORIUS AG
• SHIMADZU CORP.
• THERMO FISHER SCIENTIFIC INC.
• UNIVERCELLS TECHNOLOGIES
• WATERS CORP.